NCT04754230View on ClinicalTrials.gov

Effect of Tranexamic Acid on Postoperative Bleeding Following Sinus and Nasal Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 17, 2021

Primary Completion Date

February 20, 2022

Study Completion Date

February 20, 2022

Conditions
Chronic SinusitisNasal ObstructionTurbinate; Hypertrophy Mucous MembraneDeviated Nasal Septum - CongenitalDeviated Nasal Septum Acquired
Interventions
DRUG

Tranexamic Acid 1,000 Mg/10 mL (100 Mg/mL) INTRAVEN VIAL (ML)

Medication administered 15 minutes prior to end of surgery.

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER